TY  - GEN
AU  - Pfisterer,Jacobus
AU  - Plante,Marie
AU  - Vergote,Ignace
AU  - du Bois,Andreas
AU  - Hirte,Hal
AU  - Lacave,Angel J
AU  - Wagner,Uwe
AU  - Stähle,Anne
AU  - Stuart,Gavin
AU  - Kimmig,Rainer
AU  - Olbricht,Sigrid
AU  - Le,Tien
AU  - Emerich,Janusz
AU  - Kuhn,Walther
AU  - Bentley,James
AU  - Jackisch,Christian
AU  - Lück,Hans-Joachim
AU  - Rochon,Justine
AU  - Zimmermann,Annamaria Hayden
AU  - Eisenhauer,Elizabeth
TI  - Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG
SN  - 1527-7755
PY  - 2006///1030
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - administration & dosage
KW  - Cisplatin
KW  - Deoxycytidine
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Ovarian Neoplasms
KW  - Quality of Life
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2006.06.0913
ER  -